Evaluate the Effects of Renal Impairment on the Pharmacokinetics and Pharmacodynamics
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The study is a multicenter, Phase 1, open-label, sequential, adaptive, single dose, PK/PD
study in subjects with moderate and severe RI and healthy volunteers (HV).